摘要
尽管在药理模式取得进展,治疗眼科疾病仍然是不便捷的,创伤性的、昂贵和最终的视觉能力也常常是非常差的。多肽,作为一个蛋白质的片段,能够适当的模拟蛋白质结合因而可以作为治疗药物。化学修饰和生物工程技术被经常采用以提高多肽的效力和稳定性,因而能够增加它们的药物能力。细胞穿透多肽(CPPS),以能够穿透血清膜为特征,是著名的血障碍透过剂。他们是好的候选试剂用于携带药物穿过视觉障碍。治疗性的多肽和CPP之间是相互互补的。一旦结合,它们可能形成一个最佳的配方用于眼部的局部给药,能够发挥药效和灵活性。随后无损伤的投递和经济成本能够实现早期干预、早期治疗和长期治疗以阻止慢性的不可逆视觉失去。本文的目的在于:a)总结最近治疗性多肽,抗血管生成和抗炎作用,通过体内的动物实验来验证;b)讨论治疗性多肽的发现策略;c)展示当前视觉性治疗多肽的投递策略;d)介绍通过眼表面给药投递药物至眼部空间的CCPs。
关键词: 抗血管生成,抗炎,细胞穿透多肽,视觉药物投递,多肽设计,灵巧药物投递,治疗性多肽。
Current Medicinal Chemistry
Title:A Promising Future for Peptides in Ophthalmology: Work Effectively and Smartly
Volume: 22 Issue: 8
Author(s): Q. Sun and X. Xu
Affiliation:
关键词: 抗血管生成,抗炎,细胞穿透多肽,视觉药物投递,多肽设计,灵巧药物投递,治疗性多肽。
摘要: Despite progress in pharmacological modalities, treatments for ocular diseases are inconvenient, traumatic, costly and often end in poor final visual results. Peptides, considered as protein fragments, can adequately mimic protein binding and thus are used as therapeutic agents. Chemical modifications and bioengineering techniques are being frequently introduced to improve efficacy and stability of peptides, thereby improving their druggability. Cell-penetrating peptides (CPPs), peptides characterized by penetrating plasma membrane, are famous barrier- passers. They are good candidates for carrying drugs through ocular barriers. Therapeutic peptide and CPP perfectly complement each other. Once united, they may form an optimal formula for ocular topical administration, which can work both effectively and smartly. The consequent noninvasive delivery and economical cost would actualize prophylactic intervention, early treatment and long-term therapy to avoid chronic irreversible vision loss. The aim of the current review is a) to summarize recent therapeutic peptides, both anti-angiogenic and anti-inflammation, evidenced by animal experiments in vivo; b) to discuss the discovery strategies for therapeutic peptide; c) to present current delivery strategies for ophthalmic therapeutic peptide; and d) to introduce CPPs which are capable to deliver cargos to intraocular space via ocular surface administration.
Export Options
About this article
Cite this article as:
Q. Sun and X. Xu , A Promising Future for Peptides in Ophthalmology: Work Effectively and Smartly, Current Medicinal Chemistry 2015; 22 (8) . https://dx.doi.org/10.2174/0929867322666150114163308
DOI https://dx.doi.org/10.2174/0929867322666150114163308 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Innate Immune System and Fever under Redox Control: A Narrative
Review
Current Medicinal Chemistry AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention
Current Drug Targets Novel Drug Targets for the Treatment of Cardiac Diseases
Current Pharmacogenomics and Personalized Medicine The Role of Extracellular Nucleic Acids in Rheumatoid Arthritis
Current Pharmaceutical Biotechnology Natural Products and Cancer Stem Cells
Current Pharmaceutical Design The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Current Drug Targets Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy
Current Medicinal Chemistry Preconditioning of the Myocardium by Volatile Anesthetics
Current Medicinal Chemistry - Cardiovascular & Hematological Agents HSP70 Family in the Renal Inflammatory Response
Inflammation & Allergy - Drug Targets (Discontinued) Ameliorative Effects of GW1929, a Nonthiazolidinedione PPARγ Agonist,on Inflammation and Apoptosis in Focal Cerebral Ischemic-Reperfusion Injury
Current Neurovascular Research Effects of Hydrogen-rich Water on the PI3K/AKT Signaling Pathway in Rats with Myocardial Ischemia-reperfusion Injury
Current Molecular Medicine Target Recognition Molecules and Molecular Modeling Studies
Current Topics in Medicinal Chemistry Recent Advances in Image-Based Stem-Cell Labeling and Tracking, and Scaffold-Based Organ Development in Cardiovascular Disease
Recent Patents on Medical Imaging Connexin43 and Myocardial Ischemia-Reperfusion Injury
Cardiovascular & Hematological Disorders-Drug Targets The Role of Estrogen and Estrogen-Related Drugs in Cardiovascular Diseases
Current Drug Metabolism Recent Patents on Cardiovascular Stem Cells
Recent Patents on Cardiovascular Drug Discovery Curcumin Prevents Brain Damage and Cognitive Dysfunction During Ischemic-reperfusion Through the Regulation of miR-7-5p
Current Neurovascular Research Crocetin Attenuates Spatial Learning Dysfunction and Hippocampal Injury in a Model of Vascular Dementia
Current Neurovascular Research Experimental Brain Ischemic Preconditioning: A Concept to Putative Targets
CNS & Neurological Disorders - Drug Targets Stem Cell and Tissue Engineering Therapies for Ocular Regeneration
Current Stem Cell Research & Therapy